After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Alright, I admit that the title is a bit over the top. So, what do I mean by it? I mean that: (1) The application of PWM control to a regulator does not significantly degrade the inherent DC accuracy ...

John Devcic is a self-educated investor who began experimenting in the market as a teen and whose topics include trading strategies and charting methods. Katrina Ávila Munichiello is an experienced ...

Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.

I picked up my first weighted sleep mask years ago, hoping it would help me fall asleep and provide a calming pressure at the same time. And it became an essential part of my sleep routine for years ...